Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It
has been shown over the last decades that the reduction of atherosclerotic progression is a …

Cardiovascular disease (CVD) and cancer are the first and second leading causes of death
worldwide, respectively. Epidemiological evidence has demonstrated that the incidence of …

Objective To examine the association between serum concentrations of total cholesterol,
high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol, triglycerides …

A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis
exists. Given PON1's physical location within high‐density lipoprotein (HDL) particles and its …

Purpose The findings from epidemiologic studies of dyslipidemia and colorectal cancer risk
have been conflicting. We performed a dose–response meta-analysis of published …

Although results from in vitro studies and clinical trials demonstrate strong associations
between oxidative stress and cardiovascular risk, to date still no convincing data are …

Polycystic ovary syndrome (PCOS) is associated with altered lipid profile and increased
small, dense LDL particles (sdLDL). Considering that paraoxonase 1 (PON1) is an …

Background High-density lipoprotein cholesterol (HDL-C) plays an important role in the
reverse cholesterol transport pathway and prevents atherosclerosis-mediated disease. It has …

Abstract Paraoxonases (PONs) ie. PON1, PON2, PON3 are basically lactonases. Of these,
PON1 in addition has an efficient esterase activity and can hydrolyze organophosphates …

Glycation of apoB (apolipoprotein B) of LDL (low-density lipoprotein) increases its
atherogenicity. Concentrations of both serum glyc-apoB (glycated apoB) and SD-LDL (small …